• Citer

Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients.

par Desmedt, Christine ;Azambuja, Evandro ;Larsimont, Denis ;Delaloge, Suzette;Duhem, Caroline;Rouas, Ghizlane;Di Leo, Angelo ;D'Hondt, Veronique ;Piccart-Gebhart, Martine ;Sotiriou, Christos
Référence ASCO(2008: Chicago, Il, USA), Journal of Clinical Oncology, Proceedings of the American Society of Clinical Oncology Annual Meeting, Vol. Volume 26, Issue 15S
Publication Publié, 2008-05

Abstract de conférence

• Détails
• Contenu

Titre:	Investigating the predictive value of topoisomerase II alpha (TOP2A) gene, mRNA and protein levels in anthracycline-treated estrogen receptor (ER) negative breast cancer patients.
Auteur:	Desmedt, Christine; Azambuja, Evandro; Larsimont, Denis; Delaloge, Suzette; Duhem, Caroline; Rouas, Ghizlane; Di Leo, Angelo; D'Hondt, Veronique; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:	ASCO(2008: Chicago, Il, USA), Journal of Clinical Oncology, Proceedings of the American Society of Clinical Oncology Annual Meeting, Vol. Volume 26, Issue 15S
Statut de publication:	Publié, 2008-05
Sujet CREF:	Sciences bio-médicales et agricoles
	Médecine pathologie humaine
	Cancérologie
Langue:	Anglais